Skip to main content
. 2011 Dec;2(12):1097–1105. doi: 10.1177/1947601911423031

Figure 4.

Figure 4.

A pro-angiogenic therapy using the VEGF-VEGFR system. Recent studies suggest that sensory neurons express VEGFR-1 and motoneurons express VEGFR-2. These receptors are biologically functional, and therefore, an appropriate ligand, such as VEGF-E, can be used for pro-angiogenic therapy as well as for neuron protection therapy.